Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs Vanguard Total International Bond Index Fund ETF (BNDX) Price & Performance

AbCellera Biologics IncTrade
Vanguard Total International Bond Index Fund ETFTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Vanguard Total International Bond Index Fund ETF — how do they compare? AbCellera Biologics Inc trades at $9.24 (market cap $2.99B), while Vanguard Total International Bond Index Fund ETF trades at $47.89. The key difference: AbCellera Biologics Inc is trading nearer its 52-week high, Vanguard Total International Bond Index Fund ETF nearer its low. Which is the better fit depends on your goals.

ABCLBNDX
Market Cap
$2.99B
Sector
Health
52-Week High
$9.76$49.91
52-Week Low
$2.78$47.57
Enterprise Value
$2.58B

Returns comparison

Trailing returns across standard periods

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About Vanguard Total International Bond Index Fund ETF

The fund employs an indexing investment approach designed to track the performance of the Bloomberg Global Aggregate ex-USD Float Adjusted RIC Capped Index (USD Hedged). This index provides a broad-based measure of the global, investment-grade, fixed-rate debt markets. It is non-diversified.

Read more on BNDX